Ameriprise’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.82M | Buy |
122,026
+18,402
| +18% | +$576K | ﹤0.01% | 2548 |
|
|
2025
Q1 | $3.48M | Buy |
103,624
+11,274
| +12% | +$378K | ﹤0.01% | 2558 |
|
|
2024
Q4 | $3.62M | Buy |
92,350
+25,967
| +39% | +$1.02M | ﹤0.01% | 2578 |
|
|
2024
Q3 | $2.61M | Buy |
+66,383
| New | +$2.61M | ﹤0.01% | 2766 |
|
|
2023
Q1 | – | Sell |
-22,626
| Closed | -$891K | – | 4037 |
|
|
2022
Q4 | $891K | Sell |
22,626
-18,518
| -45% | -$729K | ﹤0.01% | 3191 |
|
|
2022
Q3 | $1.49M | Sell |
41,144
-10,032
| -20% | -$362K | ﹤0.01% | 2920 |
|
|
2022
Q2 | $1.56M | Sell |
51,176
-6,756
| -12% | -$206K | ﹤0.01% | 2916 |
|
|
2022
Q1 | $1.77M | Sell |
57,932
-389
| -0.7% | -$11.9K | ﹤0.01% | 2961 |
|
|
2021
Q4 | $1.82M | Buy |
58,321
+43,621
| +297% | +$1.36M | ﹤0.01% | 2984 |
|
|
2021
Q3 | $225K | Buy |
+14,700
| New | +$225K | ﹤0.01% | 3673 |
|